Lance Liotta and Emanuel Petricoin, co-directors of the Center for Applied Proteomics and Molecular Medicine, were honored by
Matt Kluger, vice president of research and economic development
at George Mason for their licensed patent pending, "Biomarker Isolation and Use Thereof to Characterize Physiological State" Lance Liotta, codirector of the Center for Applied Proteomics and Molecular Medicine in the Department of Molecular and Microbiology, is the 2006 recipient of a College of Arts and Sciences' Celebration of Scholarship Award. Adding to its cache of unique and rewarding international relationships, Mason and the Istituto Superiore di Sanitá of Rome, Italy, have signed a three-year agreement to develop an unprecedented proteomics research program that unveils new cancer diagnostics and therapies through the discovery of drug targets and biomarkers for early disease detection. A trial collaboration has been under way for several months at university's Center for Applied Proteomics and Molecular Medicine, (CAPMM). Matt Kluger, vice president of research and economic development
at George Mason, feels George Mason is well on its way to this approach based on existing strengths and recent recruits. He names biomedical research as one thematic research area, and notes last year's recruitment of two outstanding scientists in molecular medicine, Lance Liotta and Emanuel Petricoin III, who came from NIH and the Food and Drug Administration, respectively.
|
